Somewhat Positive Media Coverage Somewhat Unlikely to Affect Steris (STE) Share Price

News headlines about Steris (NYSE:STE) have been trending somewhat positive on Sunday, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Steris earned a news impact score of 0.17 on Accern’s scale. Accern also gave media stories about the medical equipment provider an impact score of 45.7250410047796 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Here are some of the media stories that may have impacted Accern’s analysis:

STE has been the subject of several analyst reports. KeyCorp reaffirmed an “overweight” rating and set a $101.00 target price (up from $91.00) on shares of Steris in a research report on Thursday, November 2nd. Zacks Investment Research lowered Steris from a “buy” rating to a “sell” rating in a research report on Monday, November 6th. TD Securities raised their target price on Steris from C$14.00 to C$16.00 and gave the stock a “buy” rating in a research report on Thursday, November 9th. Finally, Raymond James Financial raised their target price on Steris from $95.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, October 16th. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $79.50.

Steris (STE) traded up $1.24 during mid-day trading on Friday, hitting $91.67. The stock had a trading volume of 263,325 shares, compared to its average volume of 341,070. Steris has a 1 year low of $65.26 and a 1 year high of $93.39. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.18 and a current ratio of 2.80. The company has a market cap of $7,796.72, a price-to-earnings ratio of 54.57 and a beta of 1.27.

Steris (NYSE:STE) last posted its quarterly earnings data on Wednesday, November 1st. The medical equipment provider reported $0.94 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.95 by ($0.01). Steris had a return on equity of 11.49% and a net margin of 5.59%. The business had revenue of $634.20 million during the quarter, compared to the consensus estimate of $629.02 million. During the same period last year, the business posted $0.89 earnings per share. The business’s revenue was down 1.9% on a year-over-year basis. equities analysts forecast that Steris will post 4.06 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, December 20th. Stockholders of record on Wednesday, November 22nd were given a $0.31 dividend. This represents a $1.24 annualized dividend and a dividend yield of 1.35%. The ex-dividend date of this dividend was Tuesday, November 21st. Steris’s dividend payout ratio (DPR) is presently 73.81%.

In other news, insider Michael J. Tokich sold 11,000 shares of Steris stock in a transaction dated Monday, October 23rd. The stock was sold at an average price of $92.00, for a total value of $1,012,000.00. Following the completion of the transaction, the insider now directly owns 58,588 shares of the company’s stock, valued at approximately $5,390,096. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP John Adam Zangerle sold 3,650 shares of Steris stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $88.00, for a total value of $321,200.00. The disclosure for this sale can be found here. Company insiders own 2.55% of the company’s stock.

WARNING: This report was originally reported by Week Herald and is the property of of Week Herald. If you are reading this report on another publication, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this report can be read at https://weekherald.com/2018/01/15/somewhat-positive-media-coverage-somewhat-unlikely-to-affect-steris-ste-share-price.html.

Steris Company Profile

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Insider Buying and Selling by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply